Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective
- PMID: 12892574
Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective
Abstract
Introduction: Bladder cancer is the most common malignant tumor of the urinary system. Tobacco smoking has been implicated as a major risk factor for the development of bladder cancer and Nova Scotia has some of the highest smoking rates in Canada. We examined trends in the incidence of bladder cancer in Nova Scotia between 1980 and 1999.
Materials and methods: Data on incident cases of bladder cancer diagnosed in Nova Scotia over a twenty-year period (1980 - 1999) were obtained from the Nova Scotia Cancer Registry. The age- standardized incidence and mortality due to bladder cancer was calculated for both genders. Trends in the incidence of bladder cancer during the study period were analyzed for three different age groups in each gender as an estimate of birth cohort. The average annual percent change (AAPC) in incidence of bladder cancer was calculated.
Results: Between 1980 and 1999, 3569 cases of bladder cancer were reported (male: female = 2.9:1). The overall incidence of bladder cancer increased in both males (27.5 to 39.5 cases per 100 000) and females (7.0 to 10.7 cases per 100 000). Mortality rates were stable. There was a trend towards an increase in bladder cancer rates for all age groups analyzed, with a substantial rise occurring in females less than 65 years of age. The AAPC in incidence of bladder cancer was +1.5 for males and +2.6 for females.
Conclusions: We hypothesize that the rising incidence of bladder cancer in Nova Scotia, particularly in individuals less than 65 years of age, is related to changes in cigarette smoking practices during the past century. As the population ages, we are likely to see an increased incidence of bladder cancer in females.
Similar articles
-
Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Feb;95(2):205-12. doi: 10.1067/moe.2003.49. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003. PMID: 12582362
-
Current trends in bladder cancer in England and Wales.J Urol. 2004 Sep;172(3):1051-5. doi: 10.1097/01.ju.0000136376.11896.62. J Urol. 2004. PMID: 15311036
-
Trends in incidence and mortality from acute myocardial infarction in Nova Scotia and Saskatchewan 1974 to 1985. The Nova Scotia-Saskatchewan Cardiovascular Disease Epidemiology Group.Can J Cardiol. 1992 Apr;8(3):253-8. Can J Cardiol. 1992. PMID: 1576559
-
Bladder and kidney cancers.Cancer Surv. 1994;19-20:343-68. Cancer Surv. 1994. PMID: 7534632 Review.
-
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. Eur Urol. 2017. PMID: 27370177 Review.
Cited by
-
KIF22 promotes bladder cancer progression by activating the expression of CDCA3.Int J Mol Med. 2021 Dec;48(6):211. doi: 10.3892/ijmm.2021.5044. Epub 2021 Oct 11. Int J Mol Med. 2021. Retraction in: Int J Mol Med. 2023 Oct;52(4):92. doi: 10.3892/ijmm.2023.5295. PMID: 34633053 Free PMC article. Retracted.
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous